Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

21 Jan 2026 07:00

RNS Number : 6755P
Volex PLC
21 January 2026
 

 

21 January 2026

Volex plc

("Volex", the "Company", or the "Group")

Trading update

 

Further outperformance in Q3 supports increased expectations for the full year

 

Volex plc (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, is pleased to report a trading update for the nine months ended 31 December 2025.

 

The Group delivered a strong performance through the third quarter, building on the momentum reported at the half year. For the nine months to December 2025, Group revenue was $902.7 million, representing year-on-year organic constant currency growth of 14.8%.

The Group benefitted from particularly strong growth in Complex Industrial Technology, supported by continued, elevated demand from Data Centre customers. This reflects continued global investment in AI and digital infrastructure, supported by growth from other industrial customers remaining robust.

Across the Group's other end markets, revenues for the quarter were broadly consistent with the trends noted during the first half of the year. Electric Vehicles and Off Highway both generated organic revenue growth in the nine-month period, although Electric Vehicles organic growth moderated in Q3 due to a stronger comparative period. Although sequential performance in Medical and Consumer Electricals was stable, revenues were lower than the comparative nine-month period due to the ongoing impact of trading headwinds noted at the half year, namely destocking at a major medical customer and weaker demand for consumer appliances for the Group's European customers.

Underlying operating margins remained strong, around the upper end of the Group's 9-10% target range year-to-date, supported by pricing discipline, operational efficiencies and effective cost control.

Financial position supports continued investment for growth

The Group's balance sheet remains robust. Net debt reduced further through to December 2025, with covenant leverage1 now around 1.0x, reflecting continued cash generation and disciplined working capital management. This provides flexibility to continue investing in growth, including capacity expansion, automation, further vertical integration in support of customer demand and disciplined M&A.

Improved outlook for FY2026

The strong momentum, and good visibility through to the financial year-end provides the Board with confidence in delivering full year revenue ahead of current market consensus2. Underlying operating margins are projected to be sustained, also driving an increase in the Board's expectations for underlying operating profit3 for the full year.

While mindful of ongoing macroeconomic uncertainty and the evolving demand environment in certain end markets, the Group's exposure to diversified, structurally attractive sectors, combined with a global manufacturing footprint and strong customer relationships, supports the Board's confidence in delivering sustainable, profitable growth and long-term shareholder value.

Nat Rothschild, Chief Executive Officer of Volex, said:

"Our year-to-date performance reflects strong execution across the Group and the benefits of our exposure to structurally attractive markets. Demand from Data Centre customers has been particularly strong, driven by sustained investment in AI and digital infrastructure.

We continue to invest with discipline, maintain strong margins and a robust balance sheet. With good momentum into the final quarter, we now expect to exceed current market expectations, thereby giving increased confidence in achieving our five-year plan targets. Looking further out, we remain well positioned to deliver sustainable, long-term value for shareholders."

-ENDS-

 

 

1 Covenant leverage represents the ratio of net debt, excluding operating lease liabilities, to EBITDA excluding the impact of right of use amortisation arising on operating lease arrangements and pro-rated for acquisitions and disposals. This measure is aligned with the covenant calculations used for external debt facilities.

 2 As at 19 January 2026, the average of company compiled analysts' forecasts for the year ending 31 March 2026 for revenue is $1,152.3 million with a range of $1,145.1 million to $1,167.4 million, the average for underlying operating profit is $112.7 million, with a range of $111.7 million to $114.9 million.

3 Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

 

For further information please contact:

Volex plc +44 (0) 1256 442570

Nat Rothschild, Chief Executive Officer investor.relations@volex.com

Jon Boaden, Chief Financial Officer

Peel Hunt LLP - Nominated Adviser & Joint Broker +44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Tom Graham

 

Jefferies - Joint Broker +44 (0) 20 7029 8000

Philip NobletSam Barnett

Harry Le May

Sodali & Co. - Media Enquiries +44 (0) 20 7250 1446

James WhiteNicholas Johnson

About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 25 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

Forward looking statements

This announcement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement. Forward-looking statements should be regarded with caution as, by their nature, such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEIFASEMSEDF
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.